Latest News from: Atlantic Health System

Filters close
Released: 5-Aug-2020 12:00 PM EDT
Study Reveals New Targets for Next-Generation COVID-19 Vaccines and Tests, Beyond Antibodies
Atlantic Health System

This clinical trial increased an understanding of how T cells mount a response to COVID-19 infection. These findings pave the way for diagnostic tests that detect COVID immunity based on T cells instead of antibodies. Research demonstrates that generating neutralizing antibodies rather than T cells, may not be sufficient for long-term immunity. New discoveries suggest that vaccines will need to incorporate T cell targets to generate lasting COVID-19 immunity.

Newswise: 10 Things to Know About HPV and Throat Cancer
Released: 27-Jul-2020 4:55 PM EDT
10 Things to Know About HPV and Throat Cancer
Atlantic Health System

As we observe World Head and Neck Cancer Day 2020 (July 27), nationally known expert Tom Thomas, MD, MPH, has set out to clear up misunderstandings about how one type of head and neck cancer is related to human papillomavirus (HPV), which has historically been thought of primarily as a cause of cervical cancer. Dr. Thomas is medical director, Head and Neck Reconstructive Surgery and Transoral Robotic Surgery, Leonard B. Kahn Head and Neck Cancer Institute at Atlantic Health System’s Morristown Medical Center and Carol G. Simon Cancer Center. He is one of the leaders of the Atlantic HPV Center.

Released: 15-Jun-2020 6:00 AM EDT
5 Key Areas of Cancer Research Presented by Thought Leaders at Annual Review in Oncology Virtual Symposium
Atlantic Health System

Atlantic Health System Cancer Care will continue its tradition of world-class medical education with its 2020 Annual Review in Oncology Virtual Symposium. The symposium, held virtually this year with free registration, will take place Saturday, June 27, 2020, from 8 a.m. to 12:30 p.m. ET. Distinguished faculty from some of the Northeast’s leading cancer centers will summarize the latest advances in oncology, which have recently been presented at international conferences. The diverse range of topics should be of interest to surgeons, medical and radiation oncologists and other physicians, nurses and allied health professionals.

Released: 4-Jun-2020 5:45 AM EDT
COVID-19 Clinical Research Study Underway at Atlantic Health System, Including Immune Response Study
Atlantic Health System

The COVID Research Program is rapidly enrolling patients from New Jersey, which has one of the world’s highest concentrations of COVID-19 patients. Atlantic Health System offers a study sponsored by TScan Therapeutics, Inc., a leading T cell therapeutics company in Waltham, Massachusetts, focused on identifying the precise way the human immune system recognizes and responds to infections like COVID-19 or other diseases, like cancers. TScan has developed a novel technology that enables them to identify the natural targets of T cells.

Newswise: Study Shows Promise for Non-Small Cell Lung Cancer Patients Who Require New Treatment Options
Released: 29-May-2020 6:10 PM EDT
Study Shows Promise for Non-Small Cell Lung Cancer Patients Who Require New Treatment Options
Atlantic Health System

A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology and oncology for Atlantic Health System. Early results appear promising in this phase 1/2 clinical trial of ADXS-503 being developed by Advaxis, Inc., a new type of cancer therapy which targets “hotspot” mutations that commonly occur in specific cancer types, both by itself and in combination with immunotherapy Keytruda® (pembrolizumab), which is commonly used to treat this type of lung cancer. Dr. Haigentz and colleagues published early results of this study in conjunction with ASCO 2020, the world’s premier scientific meeting for clinical research in oncology.

Newswise: Atlantic Health System Leads Phase 1 Study on CPI-613® (Devimistat), First-in-Class Treatment for Pancreatic Cancer to be Presented at American Society of Clinical Oncology (ASCO) 2020
Released: 28-May-2020 5:00 PM EDT
Atlantic Health System Leads Phase 1 Study on CPI-613® (Devimistat), First-in-Class Treatment for Pancreatic Cancer to be Presented at American Society of Clinical Oncology (ASCO) 2020
Atlantic Health System

Dr. Alistar has pioneered the use of CPI-613® (devimistat), a unique first-in-class treatment for locally advanced or metastatic pancreatic cancer, in combination with two chemotherapy drugs. Devimistat uniquely targets enzymes involved in cancer cell metabolism, against pancreatic cancer. The study’s efficacy data suggest devimistat has synergy with chemotherapy.The current study was funded by the drug’s manufacturer, New Jersey-based Rafael Pharmaceuticals and by Atlantic Health System.

Newswise: Morristown Medical Center Raises the Roof on Cardiac Care, Completing Two-Story Expansion of New Jersey’s Leading Heart Hospital
Released: 21-Jan-2020 10:25 AM EST
Morristown Medical Center Raises the Roof on Cardiac Care, Completing Two-Story Expansion of New Jersey’s Leading Heart Hospital
Atlantic Health System

Atlantic Health System’s Morristown Medical Center, nationally recognized for heart care, today opened the second of two new 36-bed units for patients with heart disease, completing a two-story expansion of the Gagnon Cardiovascular Institute. The unit opened today will serve cardiac surgery patients, while the first 36-bed unit, which opened in November, serves structural heart disease patients who have complex disorders and diseases of the heart.

Newswise: Bonni Lee Guerin, MD Honored By American Cancer Society - Northeast Region
Released: 18-Dec-2019 10:55 AM EST
Bonni Lee Guerin, MD Honored By American Cancer Society - Northeast Region
Atlantic Health System

Bonni Lee Guerin, MD, hematologist/oncologist and physician researcher at Overlook Medical Center, was honored by the American Cancer Society for her role in advancing breast cancer treatment and prevention. In addition to her forward-looking clinical approach, Dr. Guerin is the principal investigator (PI) of numerous clinical trials exploring new ways to incorporate the latest advances in the management of breast cancer. Dr. Guerin was PI at Atlantic Health System, with the largest number of study participants of any center in the New York-New Jersey metro area, for the landmark TAILORx clinical trial.

Newswise: Advanced Lung Cancer Screening Available at Atlantic Health System
Released: 20-Nov-2019 6:05 AM EST
Advanced Lung Cancer Screening Available at Atlantic Health System
Atlantic Health System

The Atlantic Health System lung cancer test uses low-dose computed tomography (LDCT) that only takes a few minutes to complete and may identify lung cancer at earlier, more curable stages. When compared to chest X-rays used in early detection, the LDCT screening reduces lung cancer deaths in high-risk individuals by 20 percent. The screening test is covered by Medicare and most commercial insurance. Approximately 2% of screenings show early findings of lung cancer.

Newswise: Atlantic Health System Cancer Care Enrolling Patients in Innovative Pancreatic Cancer Clinical Trials
Released: 30-Oct-2019 5:50 AM EDT
Atlantic Health System Cancer Care Enrolling Patients in Innovative Pancreatic Cancer Clinical Trials
Atlantic Health System

November is national Pancreatic Cancer Awareness month. This year alone, more than 56,000 Americans will be diagnosed with pancreatic cancer. Pancreatic tumors are particularly aggressive and hard to treat "due to a mutational profile that makes it resistant to therapies that work better for other tumor types," explains Angela Alistar, MD, medical director of GI oncology at Morristown Medical Center. Dr. Alistar, an internationally known expert on pancreatic cancer, is now enrolling patients in five clinical trials aimed at pancreatic cancer.

Newswise: CAR T Cell Clinical Trial for Non-Hodgkin’s Lymphoma Begins at Atlantic Health System
Released: 25-Oct-2019 9:30 AM EDT
CAR T Cell Clinical Trial for Non-Hodgkin’s Lymphoma Begins at Atlantic Health System
Atlantic Health System

Atlantic Health System is treating patients in a new Phase 2 clinical trial of CAR T-cell therapy at Morristown Medical Center. A select number of sites across the U.S. are involved in this study, which is done on an outpatient basis. The study is sponsored by Juno Therapeutics, Inc. The study’s principal investigator, Mohamad Cherry, MD, medical director of hematology for Atlantic Health System Cancer Care, is a nationally known expert at treating and researching blood-related cancers such as lymphoma, leukemia and myeloma. Dr. Cherry is triple board-certified in internal medicine, hematology and medical oncology

Released: 23-Sep-2019 1:05 PM EDT
Overlook Medical Center Offers “Next Generation” 3-D Technology to Improve Prostate Cancer Diagnosis
Atlantic Health System

Atlantic Health System Cancer Care at Overlook Medical Center is now offering a highly advanced technology that will enhance the ability of physicians to diagnose, stage and treat prostate cancer. The UroNav Fusion Biopsy System fuses pre-biopsy magnetic resonance imaging (MRI) images of the prostate with ultrasound-guided 3-D images in real time, allowing for excellent imaging of the prostate and any abnormal changes (lesions) that may or may not be cancerous.

Newswise: 10 Things Women Should Know About Preeclampsia
Released: 19-Sep-2019 3:05 PM EDT
10 Things Women Should Know About Preeclampsia
Atlantic Health System

10 Things Women Should Know About Preeclampsia

Released: 10-Sep-2019 7:05 AM EDT
Study to Evaluate Best Medical Management for Stroke Caused by Intracerebral Hemorrhage
Atlantic Health System

The MIND study compares the safety and efficacy of a neuro-evacuation device to best medical management in evacuating intracerebral hemorrhage - a life-threatening kind of stroke which occurs when a diseased blood vessel within the brain bursts.

Newswise: New Jersey’s First National Cancer Institute Community Oncology Research Program (NCORP) Awarded to Atlantic Health Cancer Consortium
Released: 21-Aug-2019 8:45 AM EDT
New Jersey’s First National Cancer Institute Community Oncology Research Program (NCORP) Awarded to Atlantic Health Cancer Consortium
Atlantic Health System

The National Cancer Institute (NCI) has designated Atlantic Health System as a National Community Oncology Research Program (NCORP) site of the Atlantic Health Cancer Consortium (AHCC). As New Jersey’s first and only NCORP, AHCC will help develop and implement NCI cancer prevention, screening, care delivery and treatment studies with leading health care systems across the state.

Newswise: First Surgery with ROSA® Brain Robot in New Jersey 
Performed at Overlook Medical Center
Released: 29-Jul-2019 4:00 AM EDT
First Surgery with ROSA® Brain Robot in New Jersey Performed at Overlook Medical Center
Atlantic Health System

The first surgery in New Jersey using the ROSA Brain robot was performed by Ronald Benitez, MD, chief of endovascular neurosurgery, Overlook Medical Center. Conventional brain surgery for epilepsy requires a craniotomy. Using ROSA Brain, surgeons make tiny holes in the skull through which they insert electrodes to record brain activity and help pinpoint exactly which part of the brain is responsible for seizures. The robot can also assist in deep brain stimulation, trans-nasal and ventricular endoscopy, and brain biopsies.

Newswise:Video Embedded new-jersey-hospital-helps-pioneer-unique-personalized-immunotherapy-for-metastatic-melanoma
VIDEO
Released: 14-Jun-2019 12:00 AM EDT
New Jersey Hospital Helps Pioneer Unique Personalized Immunotherapy for Metastatic Melanoma
Atlantic Health System

Atlantic Melanoma Center is among the nation’s leading cancer programs participating in the clinical trials of a new type of personalized immunotherapy known as TIL (tumor infiltrating lymphocyte) therapy, in which the patient’s own immune system cells are removed from his/her tumor, treated with an immune booster and then infused back into the patient, along with a medication that stimulates the immune system. Iovance Biotherapeutics is developing TIL therapy for soild tumors and is currently conducting the pivotal study innovaTIL-01 in patients with metastatic melanoma. Atlantic Melanoma Center at Morristown Medical Center is the only site in New Jersey to treat patients with this unique experimental therapy.

Newswise: Atlantic Health System Physicians Co-Author Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Released: 31-May-2019 2:00 PM EDT
Atlantic Health System Physicians Co-Author Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Atlantic Health System

Studies to be presented at the ASCO meeting are co-authored by research oncologists Eric Whitman, MD; Missak Haigentz, MD; and Angela Alistar, MD. Their ASCO studies include: two separate studies looking at TILS therapy and Keytruda for advanced melanoma; immunotherapy for metastatic head and neck cancer; treatment for recurrent Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma; and a combination of CPI-613 -- a new type of medication, pioneered by Dr. Alistar, known as an altered energy metabolism drug -- with 5-FU in treating metastatic colorectal cancer.

Newswise: RAPID® Imaging Platform Expands Options for Speedy Stroke Treatment at Atlantic Health System Neuroscience
Released: 30-May-2019 12:40 AM EDT
RAPID® Imaging Platform Expands Options for Speedy Stroke Treatment at Atlantic Health System Neuroscience
Atlantic Health System

RAPID provides the most advanced brain imaging to stroke experts. The platform is noteworthy for its ability to shave time from the treatment decision-making process: Images are transmitted from patients’ CTA (computed tomography angiography) and CTP (computed tomography perfusion) to hospital systems and physicians’ smart phones within just minutes.

Newswise: Study Shows Simply Listening to Teens May Help Them Better Control Type 1 Diabetes
Released: 18-Apr-2019 12:05 PM EDT
Study Shows Simply Listening to Teens May Help Them Better Control Type 1 Diabetes
Atlantic Health System

Morristown Medical Center Team Finds Listening to Teens May Help Them Better Control Type 1 Diabetes

Released: 9-Apr-2019 11:05 AM EDT
Kids Vitamin D Levels Improve When Docs Do This
Atlantic Health System

Morristown Medical Center Pediatric Orthopedic Surgeon Finds Obtaining Vitamin D Levels in Children with Fractures Improves Compliance

Newswise: Study Finds These Furry Friends Calm Kids in the Hospital
Released: 3-Apr-2019 2:05 PM EDT
Study Finds These Furry Friends Calm Kids in the Hospital
Atlantic Health System

Morristown Medical Center Nursing Research Team Finds Pet Therapy Visits Reduce Anxiety in Hospitalized Children

Newswise: Atlantic Health System’s Dr. Linda Gillam Recognized with Second Top Honor from American College of Cardiology
Released: 20-Mar-2019 10:55 AM EDT
Atlantic Health System’s Dr. Linda Gillam Recognized with Second Top Honor from American College of Cardiology
Atlantic Health System

Dr. Gillam presented with Master of the ACC Award at ACC’s 68th Annual Scientific Session; was recognized in 2018 as Gifted Educator of the Year

Newswise: Morristown Medical Center’s Nationally Recognized Heart Team to be Prominently Featured at American College of Cardiology’s 68th Annual Scientific Session
Released: 14-Mar-2019 11:05 AM EDT
Morristown Medical Center’s Nationally Recognized Heart Team to be Prominently Featured at American College of Cardiology’s 68th Annual Scientific Session
Atlantic Health System

Atlantic Health System’s Morristown Medical Center, ranked one of the top 20 cardiology programs in the country by U.S. News & World Report, will be prominently featured at the American College of Cardiology’s 68th Annual Scientific Session, one of the premier meetings in the world for cardiology. The meeting will take place March 16-18 in New Orleans.

Newswise: Learn what one hospital in New Jersey is using to break new ground in non-surgical dialysis care
Released: 21-Feb-2019 9:20 AM EST
Learn what one hospital in New Jersey is using to break new ground in non-surgical dialysis care
Atlantic Health System

The WavelinQ uses radio frequency (RF), to create the connection between a vein and artery, called a fistula, which is an important step in dialysis treatment for patients. This endo-AVF (arteriovenous fistula) procedure marks the first major advancement in fistula creation in the last 50 years.

Newswise: Learn How Hospitals Get Rated in the Top 1-2% in Clinical Quality – From the Only Two to Do It in New Jersey
Released: 12-Feb-2019 8:35 AM EST
Learn How Hospitals Get Rated in the Top 1-2% in Clinical Quality – From the Only Two to Do It in New Jersey
Atlantic Health System

Atlantic Health System’s Morristown Medical Center and Overlook Medical Center were the only hospitals in New Jersey to achieve America’s 50 Best Hospitals Award™ and America’s 100 Best Hospitals Award™ from Healthgrades, respectively.

Newswise: Shopping for fitness wearables? Study says it's the information that motivates, not the device
Released: 1-Feb-2019 1:30 PM EST
Shopping for fitness wearables? Study says it's the information that motivates, not the device
Atlantic Health System

Researchers at Atlantic Sports Health found people using wearable fitness trackers mere more motivated when they had access to the information they provide, not just from wearing the device.

Newswise: Atlantic Health System, TGen and Origin Partner to Lower Barriers to Innovative Cancer Therapies
2-Oct-2018 6:05 PM EDT
Atlantic Health System, TGen and Origin Partner to Lower Barriers to Innovative Cancer Therapies
Atlantic Health System

Atlantic Health System, an integrated health care delivery system, today announced a partnership with the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and Origin Commercial Ventures to create a new platform to deliver economically viable immunotherapies and other breakthrough cancer treatments to the region through expedited access and novel payment options.

Newswise: Replacing Traditional OB/GYN Surgery with Minimally Invasive Procedures Can Shorten Hospital Stays, Allow Same-Day Discharge
Released: 4-Sep-2018 2:30 PM EDT
Replacing Traditional OB/GYN Surgery with Minimally Invasive Procedures Can Shorten Hospital Stays, Allow Same-Day Discharge
Atlantic Health System

Advances in technology are rapidly changing the way many gynecologic conditions and procedures are treated, and the traditional long hospital stays and complicated, invasive procedures requiring weeks of bedrest are being replaced with less complicated, minimally invasive procedures that simply get women back to their lives sooner.

Newswise: Atlantic Health System Enrolling Patients in Pancreatic Cancer Clinical Trials
Released: 28-Jun-2018 6:05 PM EDT
Atlantic Health System Enrolling Patients in Pancreatic Cancer Clinical Trials
Atlantic Health System

Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator (PI) on the first trial and as local PI on three other trials.

Newswise: Immunotherapy Clinical Trial Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study
Released: 29-May-2018 11:55 AM EDT
Immunotherapy Clinical Trial Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study
Atlantic Health System

Following successful Phase 1 clinical trials, the Toca regimen – a new immunotherapy for patients with recurrent brain cancer – has advanced to a Phase 3 study, which is currently underway. The trial is being conducted at 68 sites across the United States, Canada, Israel and South Korea, including at Overlook Medical Center’s Gerald J. Glasser Brain Tumor Center, one of three clinical trial sites in New Jersey. In this surgical study, patients are randomized to either standard of care treatment or the Toca regimen. Enrollment is expected to complete in this trial by the end of 2018.

Newswise: Atlantic HPV Center to Help Lead Multicenter Trial of Novel Combination Treatment for Advanced Head and Neck Cancer Caused by HPV
Released: 12-Apr-2018 11:05 AM EDT
Atlantic HPV Center to Help Lead Multicenter Trial of Novel Combination Treatment for Advanced Head and Neck Cancer Caused by HPV
Atlantic Health System

Atlantic Health System’s new Atlantic HPV Center is one of a small number of research centers in the nation to begin a study to determine whether an innovative combination of immuno-oncology treatments is safe, shows preliminary efficacy and provokes an anticancer immune system response in patients with recurrent or metastatic human papilloma virus (HPV) associated head and neck squamous cancer.

Released: 22-Feb-2018 8:05 AM EST
Cardiac Magnetic Resonance Without Intravenous Contrast May Help Better Assess Need for Mitral Valve Surgery
Atlantic Health System

Atlantic health system cardiologist authors new review on value of non-invasive imaging techniques in valvular heart disease patients

Newswise: Atlantic Health System’s Gerald J. Glasser Brain Tumor Center One of Four Sites in the Country to Offer Phase III Clinical Trial of Novel Drug VAL-083 for Late-Stage Glioblastoma
Released: 12-Jan-2018 9:40 AM EST
Atlantic Health System’s Gerald J. Glasser Brain Tumor Center One of Four Sites in the Country to Offer Phase III Clinical Trial of Novel Drug VAL-083 for Late-Stage Glioblastoma
Atlantic Health System

The Gerald J. Glasser Brain Tumor Center of Overlook Medical Center’s Atlantic Neuroscience Institute and Carol G. Simon Cancer Center is one of four sites in the country to begin a Phase III clinical trial of the novel drug VAL-083 for patients whose glioblastoma multiforme or gliosarcoma has progressed during or after treatment with the standard of care chemo-radiation therapy. Other study locations are: Kaiser Permanente Los Angeles Medical Center; University of California, San Francisco; and Dent Neurosciences Research Center, Amherst, NY.

Newswise: Dr. Mohamad Cherry of Atlantic Hematology Oncology Leads Meeting Session and Helps Present Multiple Studies at Top International Blood Cancer Meeting
Released: 7-Dec-2017 2:55 PM EST
Dr. Mohamad Cherry of Atlantic Hematology Oncology Leads Meeting Session and Helps Present Multiple Studies at Top International Blood Cancer Meeting
Atlantic Health System

Mohamad Cherry, MD, leads a major session on new discoveries about the most common type of acute adult leukemia and helps present results of four major blood cancer studies at the American Society of Hematology (ASH) 59th Annual Meeting, December 9-12 in Atlanta, GA. The meeting is the world’s pre-eminent gathering of clinicians and researchers focused on blood diseases, who travel from nearly 100 countries to hear the latest research developments. An internationally known hematology/oncology researcher, Dr. Cherry recently joined Atlantic Hematology Oncology, part of Atlantic Health System’s Atlantic Medical Group at Morristown Medical Center’s Carol G. Simon Cancer Center, from the University of Oklahoma Health Sciences Center’s Stephenson Cancer Center.

Newswise: Gastrointestinal Cancer Expert Dr. Angela Alistar Wants Public to Be Aware of Pancreatic Cancer’s Warning Signs
Released: 1-Dec-2017 2:00 PM EST
Gastrointestinal Cancer Expert Dr. Angela Alistar Wants Public to Be Aware of Pancreatic Cancer’s Warning Signs
Atlantic Health System

Nationally renowned gastrointestinal (GI) cancer physician-scientist Angela Alistar, MD thinks it is critical that everyone learn how to recognize the warning signs of pancreatic cancer. Dr. Alistar is medical director of GI medical oncology at the Carol G. Simon Cancer Center of Morristown Medical Center, Atlantic Health System.


Showing results

137 of 37

close
0.40077